Clinical Study
Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast Cancer
Table 5
Relation of Her 2/neu to p53, hormonal receptor status, grade, tumor size, lymph node status, and patients' age.
| Variable | Number |
Her2/neu+ () |
Her2/neu− () | P value | Number | % | Number | % |
| Hormonal receptor (HmR) | | | | | |
<0.0001 | HmR+ | 74 | 2 | 2.7 | 72 | 97.3 | HmR− | 21 | 18 | 85.7 | 3 | 14.3 |
p53 status | | | | | |
=0.412 | Inactive p53 | 29 | 8 | 27.6 | 21 | 72.4 | Intact P53 | 66 | 12 | 18.2 | 54 | 81.8 | Grade | | | | | |
<0.0001 | G II | 65 | 4 | 6.2 | 61 | 93.8 | G III | 30 | 16 | 53.3 | 14 | 47.7 | Tumor size | | | | | |
=1 | <5 cm | 9 | 2 | 22.2 | 7 | 77.8 | ≥5 cm | 86 | 18 | 20.1 | 68 | 79.9 | Lymph node status | | | | | |
=0.0039 | N0 | 19 | 0 | 0 | 19 | 100 | N1 | 55 | 11 | 20 | 44 | 80 | N2 | 21 | 9 | 42.9 | 12 | 57.1 | Age | | | | | |
=0.0108 | <50 years | 57 | 17 | 29.8 | 40 | 70.2 | ≥50 years | 38 | 3 | 7.9 | 35 | 92.1 |
|
|